Interactive effects of subanesthetic ketamine and subhypnotic lorazepam in humans
暂无分享,去创建一个
D. Cyril D’Souza | Dennis S. Charney | John H. Krystal | J. Douglas Bremner | Anissa Abi-Dargham | J. Krystal | D. Charney | A. Abi-Dargham | G. Heninger | J. Bremner | D. D’Souza | R. Suckow | L. Karper | A. Bennett | D. Abi‐Saab | M. B. Bowers Jr. | K. Morrissey | P. Stetson | Raymond F. Suckow | Laurence P. Karper | Alexandre Bennett | Danielle Abi-Saab | George R. Heninger | Kristen Morrissey | Philip Stetson | M. Bowers | M. B. Bowers Jr. | J. Bremner | Dennis S. Charney | D. D’Souza | John H. Krystal | Raymond F. Suckow
[1] James V. Hinrichs,et al. Ketamine: behavioral effects of subanesthetic doses. , 1984, Journal of clinical psychopharmacology.
[2] A. Agmon,et al. NMDA receptor-mediated currents are prominent in the thalamocortical synaptic response before maturation of inhibition. , 1992, Journal of neurophysiology.
[3] G. Rosenbaum,et al. Study of a new schizophrenomimetic drug; sernyl. , 1959, A.M.A. archives of neurology and psychiatry.
[4] E. Domino,et al. Pharmacologic effects of CI‐581, a new dissociative anesthetic, in man , 1965, Clinical pharmacology and therapeutics.
[5] T. Yamakura,et al. Different sensitivities of NMDA receptor channel subtypes to non-competitive antagonists. , 1993, Neuroreport.
[6] D R Medoff,et al. Ketamine activates psychosis and alters limbic blood flow in schizophrenia , 1995, Neuroreport.
[7] H. Meltzer,et al. Clinical processes and central dopaminergic activity in psychotic disorders. , 1980, Communications in psychopharmacology.
[8] P. White. Comparative Evaluation of Intravenous Agents for Rapid Sequence Induction—Thiopental, Ketamine, and Midazolam , 1982, Anesthesiology.
[9] T. Shallice,et al. Frontal lesions and sustained attention , 1987, Neuropsychologia.
[10] D. Stuss,et al. The Frontal Lobes , 1986 .
[11] M. Bell,et al. Scale for the assessment of reality testing: reliability, validity, and factorial invariance. , 1985, Journal of consulting and clinical psychology.
[12] D. Lodge,et al. The dissociative anaesthetics, ketamine and phencyclidine, selectively reduce excitation of central mammalian neurones by N‐methyl‐aspartate , 1983, British journal of pharmacology.
[13] J. Woods,et al. Stereospecific binding of 3H-phencyclidine in brain membranes. , 1982, Life sciences.
[14] R. Fragen,et al. Lorazepam Premedication: Lack of Recall and Relief of Anxiety , 1976, Anesthesia and analgesia.
[15] D. Norman. Learning and Memory , 1982 .
[16] P. Toft,et al. [Midazolam and diazepam in ketamine anesthesia]. , 1987, Ugeskrift for laeger.
[17] H. H. Kornhuber,et al. Low cerebrospinal fluid glutamate in schizophrenic patients and a new hypothesis on schizophrenia , 1980, Neuroscience Letters.
[18] J. Tuomisto,et al. Neurotransmitter regulation of anterior pituitary hormones. , 1985, Pharmacological reviews.
[19] D. Wood,et al. Total intravenous anesthesia for military surgery. A technique using ketamine, midazolam, and vecuronium , 1989 .
[20] J. Olney,et al. Glutamate receptor dysfunction and schizophrenia. , 1995, Archives of general psychiatry.
[21] R. Dingledine,et al. Involvement of N-methyl-d-aspartate Receptors in Involvement of N-methyl-d-aspartate Receptors in Epileptiform Bursting in the Rat Hippocampal Slice , 2008 .
[22] S. Sanders. The Perceptual Alteration Scale: a scale measuring dissociation. , 1986, The American journal of clinical hypnosis.
[23] J. Dundee,et al. Clinical studies of induction agents. XXXVI: Ketamine. , 1970, British journal of anaesthesia.
[24] M. Raichle,et al. The anterior cingulate cortex mediates processing selection in the Stroop attentional conflict paradigm. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[25] K. A. George,et al. Studies of drugs given before anaesthesia XXVI: lorazepam. , 1977, British journal of anaesthesia.
[26] Barbara B. Collier,et al. Ketamine and the conscious mind , 1972, Anaesthesia.
[27] J. Dundee,et al. Studies of drugs given before anaesthesia. I. A method of pre-operative assessment. , 1962, British journal of anaesthesia.
[28] P. Toft,et al. Comparison of midazolam and diazepam to supplement total intravenous anaesthesia with ketamine for endoscopy , 1987, Canadian journal of anaesthesia = Journal canadien d'anesthesie.
[29] J. Dundee. CLINICAL STUDIES OF INDUCTION AGENTS III: THE RELATIONSHIP BETWEEN DURATION OF ANAESTHESIA AND DOSAGE WITH G.29.505 , 1962 .
[30] L. Bianchi,et al. NMDA receptor antagonists decrease GABA outflow from the septum and increase acetylcholine outflow from the hippocampus: a microdialysis study , 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[31] Robert W. Buchanan,et al. The neurological evaluation scale (NES): A structured instrument for the assessment of neurological signs in schizophrenia , 1989, Psychiatry Research.
[32] J. Brodie,et al. Negative symptoms and hypofrontality in chronic schizophrenia. , 1992, Archives of general psychiatry.
[33] E. Domino,et al. Ketamine. Clinical pharmacology, pharmacokinetics and current clinical uses , 1980 .
[34] H. Tobin. Low-dose ketamine and diazepam. Use as an adjunct to local anesthesia in an office operating room. , 1982, Archives of otolaryngology.
[35] J. Leander,et al. The behavioral pharmacology of NMDA receptor antagonists. , 1990, Trends in pharmacological sciences.
[36] S. Deutsch,et al. A "glutamatergic hypothesis" of schizophrenia. Rationale for pharmacotherapy with glycine. , 1989, Clinical neuropharmacology.
[37] A. Tully,et al. Total intravenous anaesthesia for military surgery. A technique using ketamine, midazolam and vecuronium , 1988, Anaesthesia.
[38] P. Cowen,et al. Diazepam alters brain 5-HT function in man: implications for the acute and chronic effects of benzodiazepines , 1987, Psychological Medicine.
[39] R. Griffiths,et al. Lorazepam and meprobamate dose effects in humans: behavioral effects and abuse liability. , 1987, The Journal of pharmacology and experimental therapeutics.
[40] R. Kluft. An update on multiple personality disorder. , 1987, Hospital & community psychiatry.
[41] D. R. Gorham,et al. A PROVERBS TEST FOR CLINICAL AND EXPERIMENTAL USE , 1956 .
[42] J. Csernansky,et al. Rating scales in research: The case of negative symptoms , 1987, Psychiatry Research.
[43] R. Roth,et al. SEROTONIN AND DOPAMINE METABOLITES IN BRAIN REGIONS AND CEREBROSPINAL FLUID OF A PRIMATE SPECIES: EFFECTS OF KETAMINE AND FLUPHENAZINE , 1979, Journal of neurochemistry.
[44] Arthur L. Benton,et al. Word fluency and brain damage , 1967 .
[45] A. Carlsson,et al. Interactions between glutamatergic and monoaminergic systems within the basal ganglia-implications for schizophrenia and Parkinson's disease , 1990, Trends in Neurosciences.
[46] G Denes,et al. Role of the Frontal Lobes on an Attention Task: A Signal Detection Analysis , 1982, Perceptual and motor skills.
[47] S. File,et al. Interaction Between Effects of Caffeine and Lorazepam in Performance Tests and Self‐Ratings , 1982, Journal of clinical psychopharmacology.
[48] O. Wolkowitz,et al. Benzodiazepines in the treatment of schizophrenia: a review and reappraisal. , 1991, The American journal of psychiatry.
[49] S. Paul,et al. Ethanol stimulates gamma-aminobutyric acid receptor-mediated chloride transport in rat brain synaptoneurosomes. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[50] L. Grandison. Actions of benzodiazepines on the neuroendocrine system , 1983, Neuropharmacology.
[51] L. J. Chapman,et al. Reliabilities and intercorrelations of eight measures of proneness to psychosis. , 1982, Journal of consulting and clinical psychology.
[52] S. File. Effects of lorazepam on psychomotor performance: A comparison of independent-groups and repeated-measures designs , 1992, Pharmacology Biochemistry and Behavior.
[53] J. Kornhuber,et al. Regional distribution of [3H]MK-801 binding sites in the human brain , 1989, Brain Research.
[54] W K Bickel,et al. Acute effects of triazolam and lorazepam on human learning, performance and subject ratings. , 1993, The Journal of pharmacology and experimental therapeutics.
[55] I. Divac. Cortical circuits: Synaptic organization of the cerebral cortex. Structure, function and theory by Edward L. White, Birkäuser, 1989. Sw. fr. 88.00 (xvi + 223 pages) ISBN 3 7643 3402 9 , 1990, Trends in Neurosciences.
[56] D. Javitt,et al. Recent advances in the phencyclidine model of schizophrenia. , 1991, The American journal of psychiatry.
[57] Scale for the assessment of reality testing: reliability, validity, and factorial invariance. , 1985 .
[58] M. Tucker,et al. Subanesthetic doses of ketamine, diazepam, and nitrous oxide for adult outpatient sedation. , 1984, Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons.
[59] G White,et al. Ethanol inhibits NMDA-activated ion current in hippocampal neurons. , 1989, Science.
[60] K. Goldstein. Frontal lobotomy and impairment of abstract attitude. , 1949, The Journal of nervous and mental disease.
[61] D. Swandulla,et al. Differential effects of ketamine enantiomers on NMDA receptor currents in cultured neurons. , 1992, European journal of pharmacology.
[62] J. Dundee,et al. The taming of ketamine * , 1973, Anaesthesia.
[63] O. Paulsen,et al. Effects of ketamine on sensory perception: evidence for a role of N-methyl-D-aspartate receptors. , 1992, The Journal of pharmacology and experimental therapeutics.
[64] L. D. Byrd. Effects of phencyclidine and ketamine on cardiovascular activity and temperature in the squirrel monkey. , 1987, Life sciences.
[65] B. Mikkelsen,et al. REDUCTION OF PSYCHOTOMIMETIC SIDE EFFECTS OF KETALAR (KETAMINE) BY ROHYPNOL (FLUNITRAZEPAM). A RANDOMIZED, DOUBLE-BLIND TRIAL , 1977 .
[66] C. Parsons,et al. Different binding affinities of NMDA receptor channel blockers in various brain regions—Indication of NMDA receptor heterogeneity , 1995, Neuropharmacology.
[67] D. Smith,et al. The diagnosis and treatment of the PCP abuse syndrome. , 1978, NIDA research monograph.
[68] O. Paulsen,et al. The chiral forms of ketamine as probes for NMDA receptor functions in humans , 1991 .
[69] J. Olney,et al. Excitotoxicity and the NMDA receptor - still lethal after eight years , 1995, Trends in Neurosciences.
[70] M. Bowers,et al. Diazepam antagonizes effects on dopamine metabolism produced by pcp receptor agonists , 1992, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[71] I. Johnston,et al. Flumazenil in ketamine and midazolam anaesthesia , 1990, Anaesthesia.
[72] J. Dundee,et al. Ketamine-iorazepam. Attenuation of psychic sequelae of ketamine by lorazepam. , 1978, Anaesthesia.
[73] D. Cicchetti,et al. The Structured Clinical Interview for DSM-III-R Dissociative Disorders: preliminary report on a new diagnostic instrument. , 1990, The American journal of psychiatry.
[74] R. K. Siegel. Phencyclidine and ketamine intoxication: a study of four populations of recreational users. , 1978, NIDA research monograph.
[75] H. Kucera,et al. Computational analysis of present-day American English , 1967 .
[76] M. Morgan,et al. Influence of diazepam on the emergence reactions following ketamine anaesthesia , 1972, Canadian Anaesthetists' Society journal.
[77] M. Cole. The Frontal Granular Cortex and Behavior. , 1964 .
[78] M. Bowers,et al. Effects of diazepam on regional brain homovanillic acid following phencyclidine or delta 9-tetrahydrocannabinol. , 1989, Biochemical pharmacology.
[79] B. Leonard,et al. Some effects of an hallucinogenic drug (phencyclidine) on neurohumoral substances. , 1970, Life sciences. Pt. 1: Physiology and pharmacology.
[80] I. Rosén,et al. Low‐dose midazolam antagonizes cerebral metabolic stimulation by ketamine in the pig , 1993, Acta anaesthesiologica Scandinavica.
[81] P. White,et al. Ketamine--its pharmacology and therapeutic uses. , 1982, Anesthesiology.
[82] L. Hertz,et al. Ketamine-induced changes in the gaba system of mouse brain , 1980, Neuropharmacology.
[83] Herbert Weingartner,et al. NMDA Receptor Function and Human Cognition: The Effects of Ketamine in Healthy Volunteers , 1996, Neuropsychopharmacology.
[84] S. Woods,et al. m-Chlorophenylpiperazine effects in neuroleptic-free schizophrenic patients. Evidence implicating serotonergic systems in the positive symptoms of schizophrenia. , 1993, Archives of general psychiatry.
[85] S R Nelson,et al. The Influence of Droperidol, Diazepam, and Physostigmine on Ketamine‐induced Behavior and Brain Regional Glucose Utilization in Rat , 1982, Anesthesiology.
[86] G Honigfeld,et al. Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine. , 1988, Archives of general psychiatry.
[87] Dundee Jw,et al. Ketamine-iorazepam. Attenuation of psychic sequelae of ketamine by lorazepam. , 1978 .
[88] J. Overall,et al. The Brief Psychiatric Rating Scale , 1962 .
[89] Siegel Rk. Phencyclidine and ketamine intoxication: a study of four populations of recreational users. , 1978 .
[90] P. Goldman-Rakic,et al. Activation of human prefrontal cortex during spatial and nonspatial working memory tasks measured by functional MRI. , 1996, Cerebral cortex.
[91] S. Kothary,et al. Low dose intravenous infusion technique with ketamine , 1980, Anaesthesia.
[92] P. Cartwright,et al. Midazolam and diazepam in ketamine anaesthesia , 1984, Anaesthesia.
[93] Arthur L. Benton,et al. Differential behavioral effects in frontal lobe disease , 1968 .
[94] E F Domino,et al. Dissociative Anesthesia: Further Pharmacologic Studies and First Clinical Experience with the Phencyclidine Derivative Cl‐581 , 1966, Anesthesia and analgesia.
[95] D. Weinberger,et al. Physiological dysfunction of dorsolateral prefrontal cortex in schizophrenia. IV. Further evidence for regional and behavioral specificity. , 1988, Archives of general psychiatry.
[96] J. Dundee,et al. Ketamine sequelae , 1978 .
[97] Karl J. Friston,et al. Distribution of cortical neural networks involved in word comprehension and word retrieval. , 1991, Brain : a journal of neurology.
[98] B. J. Winer. Statistical Principles in Experimental Design , 1992 .
[99] A. Grace. Phasic versus tonic dopamine release and the modulation of dopamine system responsivity: A hypothesis for the etiology of schizophrenia , 1991, Neuroscience.
[100] J. Krystal,et al. Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses. , 1994, Archives of general psychiatry.
[101] J. Olney,et al. NMDA antagonist neurotoxicity: mechanism and prevention. , 1991, Science.
[102] J. Dundee,et al. Comparison of the actions of diazepam and lorazepam. , 1979, British journal of anaesthesia.